Acumen Pharmaceuticals (ABOS) Earnings Date & Reports

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABOS is expected to report earnings to rise 13.54% to -54 cents per share on August 18

Acumen Pharmaceuticals ABOS Stock Earnings Reports

Q2'25

Est.

$-0.55

Q1'25

Beat

by $0.03

Q4'24

Missed

by $0.13

Q3'24

Missed

by $0.14

Q2'24

Missed

by $0.07

The last earnings report on May 13 showed earnings per share of -47 cents, beating the estimate of -50 cents. With 249.69K shares outstanding, the current market capitalization sits at 63.00M.

View a ticker or compare two or three

Compare

ABOS